Log In
BCIQ
Print this Print this
 

BIIB067, IONIS-SOD1Rx

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense inhibitor of superoxide dismutase 1 (SOD1)
Molecular Target Superoxide dismutase 1 (SOD1)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I/II
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation
PartnerBiogen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today